18. Oral colon cancer targeting by chitosan nanocomposites
particulate mucoadhesion compared to blank
bose2018
- Bu sahifa navigatsiya:
- Grafted chitosan
- Carboxymethyl chitosan
particulate mucoadhesion compared to blank | |||
| |||
|
|
chitosan nanoparticles. It infers that such drug |
|
|
|
delivery system can confer a higher drug |
|
|
|
bioavailability |
|
Gemcitabine |
Gemcitabine loaded nanoparticles were prepared |
The cytotoxicity of the gemcitabine loaded |
[21] |
|
by ionic gelation method using chitosan and |
nanoparticles in HT-29 colon cancer cell line |
|
|
Pluronic F-127 and their anticancer activity |
is found to be satisfactory |
|
|
was tested in vitro by cell culture study |
|
|
Hydroxycamptothecin |
The chemotherapeutic drug hydroxycamptothecin |
The nanoparticles adopted a sustained release |
[22] |
|
was loaded into poly(lactide-co-glycolide)- |
phase preceded by initial burst release of drug |
|
|
chitosan nanoparticles and its anticancer |
that is reduced by chitosan coating. The |
|
|
activity was tested in vitro by cell culture study |
cytotoxicity of the chitosan-based nanoparticles |
|
|
|
in A549 and HT29 cells is positive |
|
(Continued)
Table 18.2 (Continued)
Candidate |
Experiment |
Remark |
Reference |
5-Fluorouracil |
The chitosan-based formulation was converted |
The chitosan-based formulation is susceptible to |
[23] |
|
into tablet by compression coating technique |
degradation by colonic enzymes which |
|
|
using granulated system |
implies its possibility for use in oral colon- |
|
|
|
specific drug delivery |
|
Survivin |
The survivin was incorporated in mucoadhesive |
The survivin-chitosan nanoparticles protect |
[24] |
|
chitosan nanoparticles with the latter subjected |
primary cells from autophagy and |
|
|
to molecular biology evaluation |
successfully induce tumor-specific apoptosis |
|
|
|
via both extrinsic and intrinsic apoptotic |
|
|
|
pathways |
|
Paclitaxel |
Delivery system constituted of chitosan and |
The highest mucin-producing cell line Calu-3 |
[25] |
|
glycerylmonooleate in 0.33M citric acid |
cells are characterized by the lowest |
|
|
containing paclitaxel was designed and subjected |
percentage of drug transport from gels in |
|
|
to drug transport study using different mucin- |
comparison to Caco-2 cells |
|
|
producing cell lines (Calu-3, Caco-2) |
|
|
Celecoxib |
Films made of chitosan and guar gum were |
Local high concentrations of drug are shown to |
[26] |
|
prepared with celecoxib loading and subjected |
impede the proliferation of HT-29 colon |
|
|
to anticancer activity evaluation |
carcinoma cell directly, while chemo- |
|
|
|
prevention has been demonstrated using low |
|
|
|
drug doses in in vitro cell culture study |
|
Iron loaded bovine |
Fe-bLf or Taxol was adsorbed onto calcium |
Fe-bLf or Taxol, as oral nanoformulations, |
[27] |
lactoferrin (Fe-bLf) |
phosphate nanocores, enclosed in |
provides a significant regression in the tumor |
|
or paclitaxel |
biodegradable chitosan and alginate |
size as compared to intra-tumoral injection of |
|
(Taxol) |
|
Taxol |
|
5-Aminolevulinic |
Chitosan was mixed with sodium |
The nanoparticles could exclude the influence |
[28] |
acid |
tripolyphosphate and 5-aminolevulinic acid to |
of normal flora inside the gut and serve as a |
|
|
form crosslinked nanoparticles |
tool for fluorescent endoscopic detection of |
|
|
|
colorectal cancer cells in vivo |
|
Oral colon cancer targeting by chitosan nanocomposites 415
Grafted chitosan
Trimethyl chitosan
—
Trimethylated chitosan is a partially quarternized chitosan derivative that is freely soluble in water over a wide range of pH. It is obtained by reductive methylation of chitosan using methyl iodide in the presence of a strong base such as sodium hydrox- ide at 60◦C [29 32]. This soluble chitosan derivative has mucoadhesive properties and exhibits good absorption-enhancing properties, even at neutral pH [33,34]. Its capability as absorption enhancer is ascribed to its ability to open the tight junctions between adjacent epithelial cells through interactions between the protonated (posi- tively charged) amino groups on the C-2 position and the negatively charged sites on the cell membrane and/or in the tight junctions [35]. Trimethyl chitosan has positive charges, independently of the pH, at all degrees of quarternization [36]. An increase in the degree of quarternization increases its permeation-enhancing effect [32,36,37]. Table 18.3 summarizes the outcome of trimethyl chitosan as nanocarrier of anticancer therapeutics for colon cancer treatment.
Carboxymethyl chitosan
Carboxymethyl chitosan is synthesized by introducing a carboxymethyl group in the parent structure of chitosan. It is prepared by carboxymethylation of the hydroxyl and amine moieties of chitosan. This modification increases chitosan’s solubility in neutral and basic solutions without affecting other important character- istics. Carboxymethyl chitosan nanoparticles have been prepared as carriers for some anticancer drugs. Carboxymethyl chitosan with different molecular weights
Table 18.3 Experimental studies of trimethyl chitosan as anticolon cancer drug nanocarrier
Candidate |
Experiment |
Remark |
Reference |
hSET1 antisense RNA and SN38 anticancer drugs |
hSET1 antisense RNA and SN38 anticancer drugs were embedded in nanoparticles made of cysteine trimethyl chitosan and carboxymethyl dextran. The anticancer efficacy of nanoparticles was examined in vitro using HT29 cancerous cell line |
The nanoparticles are found to exhibit anticancer activity via inhibiting topoisomerase that participates in the overwinding or underwinding of DNA |
[38] |
416 Applications of Nanocomposite Materials in Drug Delivery
and degrees of carboxymethyl substitution is used to prepare nanoparticles through ionotropic gelation with calcium ions [39]. Table 18.4 summarizes the outcome of carboxymethyl chitosan as nanocarrier of anticancer therapeutics for colon cancer treatment.
Do'stlaringiz bilan baham:
ma'muriyatiga murojaat qiling